- Disease: Acute SARS-CoV-2
- Study type: Observational Cohort Study
- Study type descriptors: Prospective, Single centre
- Study aim: To describe the clinical evolution of kidney transplant receipients with SARS-CoV-2 infection treated with molnupiravir and the possible interactions between molnupiravir and the immunosuppressive treatment.
- Number of participants enrolled: 9
- Study enrolling from to
- Study includes follow-up for 1 month
Study Data
- Adults
- Fragile population
- Hospital wide
- Outpatient clinic
- SARS-CoV-2
- Acute SARS-CoV-2
- Blood sample
- Pharmacological intervention
- Antivirals
- Molnupiravir
External Links
Other information
If you would like to contact the Principal Investigator of the study please email: ccb@ateneo.univr.it
The data is updated up to